Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retagliptin Phosphate + Metformin in T2DM
NCT05054842Phase 3Unknown
- Sponsor
- Hengrui
- Start
- Dec 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of retagliptin in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Status: unknown.
02
Drugs
retagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05054842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05054842.